{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:24:00Z","timestamp":1789399440361,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002603","name":"American Society for Reproductive Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002603","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.fertnstert.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T16:23:33Z","timestamp":1655051013000},"page":"266-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in\u00a0vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2151-4652","authenticated-orcid":false,"given":"Yanett","family":"Anaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Letourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Lenhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor","family":"Juarez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Jalalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle I.","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2022.05.006_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/humupd\/dmx040","article-title":"Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events","volume":"24","author":"Conti","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib2","first-page":"696","article-title":"Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea","volume":"90","author":"Rao","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1210\/jcem-28-12-1763","article-title":"Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man","volume":"28","author":"Yen","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of exogenously administered human chorionic gonadotropin","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","article-title":"Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in\u00a0vitro fertilization","volume":"82","author":"Schmidt","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1472-6483(10)60668-2","article-title":"Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles","volume":"14","author":"Nargund","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib8","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.fertnstert.2006.12.058","volume":"88","author":"Kolibianakis","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11596-013-1085-z","article-title":"Minimum dose of hCG to trigger final oocyte maturation and prevent OHSS in a long GnRHa protocol","volume":"33","author":"Chen","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0015-0282(16)59591-0","article-title":"The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in\u00a0vitro fertilization program","volume":"48","author":"Abdalla","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01131622","article-title":"Ultrasonic assessment of endometrial changes in stimulated cycles in an in\u00a0vitro fertilization and embryo transfer program","volume":"1","author":"Smith","year":"1984","journal-title":"J In\u00a0Vitro Fert Embryo Transf"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0015-0282(16)48732-7","article-title":"Successful pregnancies from the transfer of pronucleate embryos in an outpatient in\u00a0vitro fertilization program","volume":"44","author":"Ahuja","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0030-1265674","article-title":"Ovarian hyperstimulation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose","volume":"28","author":"Kashyap","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fertnstert.2004.12.053","article-title":"Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in\u00a0vitro fertilization","volume":"84","author":"Shapiro","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0301-2115(99)00152-9","article-title":"Borderline form of empty follicle syndrome: is it really an entity?","volume":"88","author":"I\u015fik","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","article-title":"Hormonal dynamics at midcycle: A reevaluation","volume":"57","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)45249-0","article-title":"The use of gonadotropins for induction of ovulation","volume":"35","author":"Schwartz","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","article-title":"Clinical effect of human pituitary follicle-stimulating hormone (FSH)","volume":"18","author":"Gemzell","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib19","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/endo.133.6.8243314","article-title":"Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone","volume":"133","author":"Tapanainen","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/molehr\/5.8.726","article-title":"FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms","volume":"5","author":"Andersen","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1472-6483(10)61826-3","article-title":"Effect of FSH and its different isoforms on maturation of oocytes\u00a0from pre-ovulatory follicles","volume":"5","author":"Andersen","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib23","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1016\/S0021-9258(17)33113-7","article-title":"Studies on the role of plasminogen activator in ovulation. In\u00a0vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins","volume":"251","author":"Strickland","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/endo-116-2-516","article-title":"Follicular plasminogen activator: involvement in ovulation","volume":"116","author":"Reich","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1210\/en.2015-1727","article-title":"FSH regulates mRNA translation in mouse oocytes and promotes developmental competence","volume":"157","author":"Franciosi","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib26","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/endo-127-6-3023","article-title":"Recombinant follicle-stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats","volume":"127","author":"Galway","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/humrep\/13.3.554","article-title":"A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques","volume":"13","author":"Zelinski-Wooten","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0024-3205(93)90608-6","article-title":"Pure FSH alone induces ovulation and subsequent pregnancy in the mouse resulting in fetal development","volume":"53","author":"Rice","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib29","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/endo.132.5.8477652","article-title":"Human chorionic gonadotropin or human recombinant follicle-stimulating hormone (FSH)-induced ovulation and subsequent fertilization and early embryo development in hypophysectomized FSH-primed mice","volume":"132","author":"Wang","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib30","doi-asserted-by":"crossref","first-page":"1747.e1","DOI":"10.1016\/j.fertnstert.2009.07.998","article-title":"Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program","volume":"92","author":"Bianchi","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0015-0282(16)54125-9","article-title":"Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in\u00a0vitro fertilization","volume":"55","author":"Imoedemhe","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2008.12.015","article-title":"Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program","volume":"93","author":"Erb","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.fertnstert.2011.01.019","article-title":"Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in\u00a0vitro fertilization\u00a0cycles: a randomized, double-blind, placebo-controlled trial","volume":"95","author":"Lamb","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10815-017-1074-4","article-title":"A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in\u00a0vitro fertilization stimulation protocols","volume":"35","author":"Anaya","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib40","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2007.02.011","article-title":"A quantitative assessment of follicle size on oocyte developmental competence","volume":"90","author":"Rosen","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01130729","article-title":"Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration","volume":"6","author":"Scott","year":"1989","journal-title":"J In\u00a0Vitro Fert Embryo Transf"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib42","series-title":"Handbook of the laboratory diagnosis and treatment of infertility Veeck L. The morphological assessment of human oocytes and early conception","first-page":"353","article-title":"The morphological assessment of human oocytes and early conception","author":"Veeck","year":"1990"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib43","series-title":"Toward reproductive certainty: fertility and genetics beyond 1999: the plenary proceedings of the 11th World Congress on In\u00a0Vitro Fertilization and Human Reproductive Genetics","first-page":"378","article-title":"In\u00a0vitro culture of human blastocysts","author":"Gardner","year":"1999"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.fertnstert.2020.11.012","article-title":"Developing a core outcome set for future infertility research: an international consensus development study","volume":"115","author":"Duffy","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10815-012-9852-5","article-title":"Metaphase II (MII) oocytes obtained at different time points in the same in\u00a0vitro fertilization cycle","volume":"29","author":"Cakmak","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fendo.2018.00193","article-title":"Follicle size on day of trigger most likely to yield a mature oocyte","volume":"9","author":"Abbara","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7827-12-107","article-title":"A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome?","volume":"12","author":"Revelli","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176019","article-title":"Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: analysis of 10,427 IVF-ICSI cycles","volume":"12","author":"Gunnala","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib49","doi-asserted-by":"crossref","first-page":"537205","DOI":"10.3389\/fendo.2020.537205","article-title":"Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and kisspeptin during IVF treatment","volume":"11","author":"Abbara","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib50","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib51","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2006.12.006","article-title":"Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles","volume":"88","author":"Griesinger","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib52","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1586\/17446651.2015.969711","article-title":"Luteinizing hormone and human chorionic gonadotropin: a review of their varied clinical applications in assisted reproductive technology","volume":"10","author":"Choi","year":"2015","journal-title":"Expert Rev. Endocrinol. Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib54","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/humrep\/det055","article-title":"Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity","volume":"28","author":"Evans","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib55","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.fertnstert.2013.05.028","article-title":"Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support\u00a0used in recombinant follicle-stimulating hormone\u2013gonadotropin-releasing hormone antagonist in\u00a0vitro fertilization cycles","volume":"100","author":"Fatemi","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","article-title":"Evidence of impaired endometrial receptivity after ovarian stimulation for in\u00a0vitro fertilization: a prospective randomized trial comparing fresh and frozen\u2013thawed embryo transfer in normal responders","volume":"96","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"Improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"Andersen","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.fertnstert.2020.05.022","article-title":"Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin","volume":"114","author":"Andersen","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","article-title":"Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome","volume":"344","author":"McClure","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib62","first-page":"1967","article-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial\u00a0growth factor and interleukins in the pathogenesis of severe\u00a0ovarian hyperstimulation\u00a0syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib64","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/humrep\/12.6.1129","article-title":"The pathophysiology of ovarian hyperstimulation syndrome - views and ideas","volume":"12","author":"Elchalal","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib65","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI4814","article-title":"Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome","volume":"102","author":"Levin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib66","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1210\/jcem.87.7.8651","article-title":"Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor","volume":"87","author":"Wang","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib67","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(98)00221-0","article-title":"Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in\u00a0vitro fertilization program","volume":"70","author":"Artini","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(98)00249-0","article-title":"Serum vascular endothelial growth factor and Doppler blood flow velocities in in\u00a0vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries","volume":"70","author":"Agrawal","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib69","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in\u00a0vivo studies investigating the role of interleukin-1\u03b2, interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib70","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib71","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.05.006_bib72","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10815-016-0755-8","article-title":"GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone","volume":"33","author":"O\u2019Neill","year":"2016","journal-title":"J Assist Reprod Genet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:35:00Z","timestamp":1758011700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028222002850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0015028222002850"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.05.006","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in\u00a0vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92022 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}